Fortress Biotech (FBIO) News Today $1.91 +0.08 (+4.32%) Closing price 07/3/2025 03:36 PM EasternExtended Trading$1.88 -0.03 (-1.78%) As of 07:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FBIO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period FBIO Fortress Biotech, Inc. - Seeking AlphaJune 26, 2025 | seekingalpha.comJourney Medical to Join Russell 2000® and Russell 3000® IndexesJune 24, 2025 | globenewswire.comFortress Biotech (NASDAQ:FBIO) Stock Passes Above 200-Day Moving Average - Here's WhyJune 21, 2025 | marketbeat.comJourney Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology ConferenceJune 20, 2025 | globenewswire.comJourney Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TVJune 9, 2025 | globenewswire.comFortress Biotech (NASDAQ:FBIO) Shares Pass Above Two Hundred Day Moving Average - Time to Sell?June 3, 2025 | marketbeat.comFortress Biotech Announces Closing of Sale of Subsidiary Checkpoint TherapeuticsMay 30, 2025 | globenewswire.comRoth Capital Predicts Higher Earnings for Fortress BiotechMay 24, 2025 | marketbeat.comFortress Biotech (NASDAQ:FBIO) Shares Pass Above Two Hundred Day Moving Average - Should You Sell?May 24, 2025 | marketbeat.comFortress Biotech, Inc.: Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate HighlightsMay 16, 2025 | finanznachrichten.deFortress Biotech (FBIO) Projected to Post Quarterly Earnings on WednesdayMay 16, 2025 | marketbeat.comFortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate HighlightsMay 15, 2025 | globenewswire.comJourney Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate HighlightsMay 14, 2025 | globenewswire.comCheckpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate UpdatesMay 13, 2025 | globenewswire.comJourney Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025May 7, 2025 | globenewswire.comFortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual ConferenceMay 7, 2025 | globenewswire.comThis Fortress Biotech Insider Increased Their Holding By 26% Last YearApril 9, 2025 | finance.yahoo.comJourney Medical Corporation Appoints Ramsey Alloush as Chief Operating OfficerApril 1, 2025 | globenewswire.comFortress Biotech Reports 2024 Financial Results and Recent Corporate HighlightsMarch 31, 2025 | globenewswire.comCheckpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate UpdatesMarch 28, 2025 | globenewswire.comFortress Biotech, Inc. (FBIO) Q4 2024 Earnings Call TranscriptMarch 26, 2025 | seekingalpha.comJourney Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate HighlightsMarch 26, 2025 | globenewswire.comFortress Biotech FY 2024 Earnings PreviewMarch 25, 2025 | msn.comJourney Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of RosaceaMarch 24, 2025 | globenewswire.comJourney Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025March 19, 2025 | globenewswire.comPartex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI PlatformMarch 17, 2025 | globenewswire.comJourney Medical Corporation to Participate in the 37th Annual ROTH ConferenceMarch 12, 2025 | globenewswire.comJulie & Holleman LLP: CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun PharmaMarch 11, 2025 | finanznachrichten.deFortress Biotech price target raised to $16 from $15 at Roth MKMMarch 11, 2025 | markets.businessinsider.comRoth MKM Remains a Buy on Fortress Biotech (FBIO)March 11, 2025 | markets.businessinsider.comCKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun PharmaMarch 10, 2025 | prnewswire.comSun Pharma to Acquire Checkpoint TherapeuticsMarch 9, 2025 | prnewswire.comMustang Bio Regains Compliance with Nasdaq Capital Market RequirementMarch 5, 2025 | globenewswire.comJourney Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat RosaceaMarch 5, 2025 | globenewswire.comJourney Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, FloridaMarch 4, 2025 | globenewswire.comMustang Bio sets terms for $8M public offeringFebruary 6, 2025 | msn.comFortress Biotech announces first patient dosed in Phase 2 trial of TriplexJanuary 27, 2025 | markets.businessinsider.comFortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCTJanuary 27, 2025 | globenewswire.comJourney Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of RosaceaJanuary 23, 2025 | globenewswire.comShort Interest in Fortress Biotech, Inc. (NASDAQ:FBIO) Expands By 9.3%January 18, 2025 | marketbeat.comFDA extends review of Fortress Biotech's CUTX-101 drugJanuary 16, 2025 | msn.comFortress, Cyprium announce FDA acceptance, priority review of NDA for CUTX-101January 7, 2025 | markets.businessinsider.comFortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes DiseaseJanuary 6, 2025 | globenewswire.comSentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper Histidinate) Product Candidate for Treatment of Menkes DiseaseJanuary 6, 2025 | prnewswire.comFortress Biotech (NASDAQ:FBIO) Stock Price Passes Above 200-Day Moving Average - What's Next?January 1, 2025 | marketbeat.comFortress Biotech, Inc. Common Stock (FBIO) Analyst ResearchDecember 23, 2024 | nasdaq.comCheckpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl)December 13, 2024 | globenewswire.comFortress Biotech price target raised to $15 from $13 at Roth MKMNovember 20, 2024 | markets.businessinsider.comFortress Biotech price target raised to $26 from $24 at H.C. WainwrightNovember 18, 2024 | markets.businessinsider.comFortress Biotech price target lowered to $4 from $5 at Alliance Global PartnersNovember 18, 2024 | markets.businessinsider.com Get Fortress Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for FBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address FBIO Media Mentions By Week FBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FBIO News Sentiment▼0.000.58▲Average Medical News Sentiment FBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FBIO Articles This Week▼01▲FBIO Articles Average Week Get Fortress Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for FBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CDXS News AGEN News SGMO News IRWD News DOMH News ACHV News CRIS News SABS News BOLT News MTEM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FBIO) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortress Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortress Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
